Aurobindo this week broke ground on the 567,000-square-foot facility that is slated to include a manufacturing and distribution center and warehouse.

Keryx Biopharmaceuticals, which was already dealing with slow uptake of its kidney drug Auryxia, now has a bigger issue with which to deal: No product to sell.

Sagent Pharmaceuticals will soon have a new Japanese owner, but for now any recalls are all on the U.S. injectable drug manufacturer. And it has another recall…

GlaxoSmithKline is not planning to exit the U.K. just because the U.K. is exiting the European Union. As if to emphasize its commitment, the drugmaker today…

Noven has been recalling tens of thousands of boxes of its Daytrana patches from the market because of issues over peeling away a protective liner to deliver…

Pfizer’s biologics manufacturing plant in Dublin is one of the largest in the world but will get bigger yet as the drugmaker expands the facility, in part, to…

Epilepsy patients in Canada are scrambling to find supplies of seizure drug clobazam after a supply interruptions at Canada’s largest drug company and another…

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player.